Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 380

Results For "MED"

5416 News Found

Cionic’s Neural Sleeve granted USFDA clearance
Medical Device | March 08, 2022

Cionic’s Neural Sleeve granted USFDA clearance

Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities


IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year
News | March 07, 2022

IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year

The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business


AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
People | March 07, 2022

AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer

Dr. Bibikova is an international leader with over 25 years of experience in genomics industry


Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease
Drug Approval | March 07, 2022

Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease

OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)


Thermo Fisher Scientific unveils new genetic analyzer
Medical Device | March 07, 2022

Thermo Fisher Scientific unveils new genetic analyzer

Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe


AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
Sustainability | March 07, 2022

AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru

Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation


Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer
Biotech | March 07, 2022

Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer

Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)


Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
Biotech | March 07, 2022

Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases

Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.


Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix
Biotech | March 07, 2022

Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix

This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients